Trial
NCT03519984
EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI); Vasgene Therapeutics, Inc; Whittier Foundation
Condition
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Intervention
Cytarabine
Why stopped
Study drug supply issue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-30